Focus Taiwan App
Download

Taiwan biomedical sector to see biggest overseas funding case

10/28/2020 01:12 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Oct. 28 (CNA) Taipei-based Oneness Biotech Co. Ltd. (合一生技) set the price for its global depositary receipt (GDR) issuance on Wednesday that will make it the biggest ever overseas fundraising case by a company in Taiwan's biomedical sector.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.192